CMET-46. INITIAL CLINICAL AND ADVANCED IMAGING OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I DOSE-ESCALATION TRIAL OF RRX-001 PLUS WHOLE BRAIN RADIATION FOR PATIENTS WITH BRAIN METASTASES

BACKGROUND: RRx-001, a novel redox modulator was evaluated as a potential radiosensitizer with WBRT in a multicenter phase I trial for adults with brain metastases. The primary endpoint was to determine MTD. Secondary endpoints included intracranial response rate (IRR), survival and correlation of D...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Kim, Michelle, Parmar, Hemant, Aryal, Madhava, Schipper, Matthew, Devasia, Theresa, Kesari, Santosh, Morikawa, Aki, Spratt, Daniel, Junck, Larry, Hayman, James, Lawrence, Theodore, Tsien, Christina, Aiken, Robert, Goyal, Sharad, Knox, Susan, Caroen, Scott, Carter, Corey, Oronsky, Bryan, Cao, Yue, Lao, Christopher
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217024/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.255
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados